Suchergebnisse - "Wang, Han-Lei"

PubPharm (20)

1

Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Luo, P. | Mo, D. | Wang, H. | +2

2

Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma

enthalten in: The Lancet. Oncology | 2023

von Mo, D. | Huang, J. | Luo, P. | +2

CommentOn: Lancet Oncol. 2023 Mar;24(3):252-261. - PMID 36858722

3

Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Huang, S. | Luo, P. | Wang, H. | +2

CommentOn: J Clin Oncol. 2023 Mar 10;41(8):1600-1609. - PMID 36413710

4

Triterpenoids from Kochiae Fructus : Glucose Uptake in 3T3-L1 Adipocytes and α-Glucosidase Inhibition, In Silico Molecular Docking

enthalten in: International journal of molecular sciences | 2023

von Chen, X. | Zhang, K. | Zhao, X. | +5

5

PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma

enthalten in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2023

von Mo, D. | Huang, J. | Luo, P. | +3

6

Efficacy and safety of adjuvant therapy with PD‑1/PD‑L1 inhibitors in cancer

enthalten in: Experimental and therapeutic medicine | 2022

von Mo, D. | Liang, Z. | Chen, L. | +3

7

Kochiae Fructus : Evaluation on the antioxidant properties and oral safety of its water decoction

enthalten in: Toxicon : official journal of the International Society on Toxinology | 2022

von Chen, X. | Li, B. | Zhao, X. | +5

8

Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers : A meta-analysis of randomized controlled trials

enthalten in: Medicine | 2022

von Mo, D. | Huang, J. | Luo, P. | +2

9

The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer : a meta-analysis

enthalten in: Investigational new drugs | 2022

von Meng, L. | Huang, J. | Luo, P. | +2

10

PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma

enthalten in: European archives of oto-rhino-laryngology and head & neck | 2022

von Mo, D. | Huang, J. | Luo, P. | +3